Research Article
A Combination of UTMD-Mediated HIF-1α shRNA Transfection and TAE in the Treatment of Hepatic Cancer
Figure 8
The VEGF protein expression of hepatoma tissue in the four groups on day 14 (×400 folds). (a) Control group; (b) UTMD group; (c) TAE group; (d) UTMD+TAE group.
(a) |
(b) |
(c) |
(d) |